BSMO Sponsored trials
Precision medicine seeks to identify the best treat¬ment for each individual based on the pa¬tient’s unique characteristics. This approach could …
Precision medicine seeks to identify the best treat¬ment for each individual based on the pa¬tient’s unique characteristics. This approach could …
“Breast Cancer Debate of the Year” and The “Best of SABCS™ 2017” symposia Friday January 26th, 2018 and Saturday January …
The U.S. Food and Drug Administration today approved bevacizumab-awwb (Mvasi) as a biosimilar to bevacizumab (Avastin) for the treatment of multiple types …